Icagen Setting Up to Break Out

Shares of Icagen ICGN are trading higher on the session by 8.61%, at $8.07. The stock has been spiking higher and higher on takeover chatter for the past month and it looks like shares could make another leap higher very soon. Icagen's most recent high is at $8.20. Shares are inching toward that level today, most recently breaking out of the $8.00 intra-day resistance level. Volume is running at 1.5x the 10-day daily average. Icagen has 2.66% short interest. Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally-administered small molecule drugs that modulate ion channel targets.